CSLLY
PINK CSL Limited Sponsored ADR$32.00 ↑ +0.00 (+0.00%) Trading Up from the previous close of $32.00, $0.05 below the day’s high of $32.05
- YTD change
- -44.44%
- vs 20-day SMA
- +2.67%
- vs 200-day SMA
- -3.56%
Price ranges
Price & Performance
+7.98 (+33.22%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 72.9% away from all-time highs of $117.98
- CSLLY is down 44% since the beginning of the year
- CSLLY is down 50% over the past 12 months
- CSLLY is up 2% over the past 1 month
CSLLY reads very good: price sits above one of the two key moving averages, the 12-month move is -51.2%.
- Previous minute
- +$0.00
- Last hour
- +$0.01
- Last 5 days
- +2.89%
- vs 8-day SMA
- +1.74%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment provides plasma products, gene therapies, and recombinants. The CSL Seqirus segment includes predominantly influenza related products and provides pandemic services to governments. The CSL Vidor segment focuses on the distribution of products in the therapeutic areas of iron deficiency and nephrology. The company was founded on November 2, 1961 and is headquartered in Melbourne, Australia.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
